Crossmark

Early and eighteen month clinical outcomes of first UK case of percutaneous deep vein arterialisation (pDVA) to treat “no option” chronic limb-threatening ischemia using the LimFlow system

Crossref DOI link: https://doi.org/10.1186/s42155-021-00252-4

Published Online: 2021-08-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lechareas, Symeon http://orcid.org/0000-0003-3859-2980
Sritharan, Kaji

Williams, R. G. Mc
License Information

Text and Data Mining valid from 2021-08-09

Version of Record valid from 2021-08-09
More Information

Article History

Received: 3 April 2021

Accepted: 30 July 2021

First Online: 9 August 2021

Declarations

:

: The pVDA procedure received approval from the new devices and new techniques committee and the ethics committee of our Trust. Written informed consent was obtained from the patient for all the procedures described in this study.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below